Literature DB >> 1934632

Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children.

V K Singh1, R P Warren, J D Odell, P Cole.   

Abstract

Immune abnormalities in autistic children led us to study for indirect evidence of immune activation as measured by the serum analysis of soluble interleukin-2 (sIL-2), interleukin-2 receptor (sIL-2R), T8 antigen (sT8), and interleukin-1 (sIL-1). The serum concentration of these soluble antigens was quantitated by enzyme-linked immunosorbent assays. The concentration of sIL-2 and sT8, but not of sIL-2R and sIL-1, antigens was significantly (P less than 0.05) increased in the sera of autistic children over that in the control healthy children or children with mental retardation (non-Down's syndrome). This finding indirectly indicates that the activation of a subpopulation of T cells occurs in some children with autism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934632     DOI: 10.1016/s0090-1229(05)80015-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  22 in total

1.  Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

Authors:  G DelGiudice-Asch; L Simon; J Schmeidler; C Cunningham-Rundles; E Hollander
Journal:  J Autism Dev Disord       Date:  1999-04

2.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

Review 3.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

4.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

5.  Cytokine Profile in Autism Spectrum Disorders in Children.

Authors:  Vesna Bryn; Hans Christian Dalsbotten Aass; Ola H Skjeldal; Jørn Isaksen; Ola Didrik Saugstad; Heidi Ormstad
Journal:  J Mol Neurosci       Date:  2016-10-12       Impact factor: 3.444

Review 6.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

7.  Interferonemia and autism.

Authors:  G Stubbs
Journal:  J Autism Dev Disord       Date:  1995-02

8.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-08-10       Impact factor: 7.217

9.  Lymphocyte subsets and interleukin-2 receptors in autistic children.

Authors:  D R Denney; B W Frei; G R Gaffney
Journal:  J Autism Dev Disord       Date:  1996-02

10.  Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry.

Authors:  Regina Taurines; Edward Dudley; Alexander C Conner; Julia Grassl; Thomas Jans; Frank Guderian; Claudia Mehler-Wex; Andreas Warnke; Manfred Gerlach; Johannes Thome
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-27       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.